State coverage
Florida Medicaid and GLP-1 coverage
Medicaid, for obesity: Does not cover. The conditions and the appeal deadline are in the summary below.
At a glance
- Medicaid, for obesity
- Weight control medications are a named exclusion, in a coverage policy still dated December 2017.
- Appeal deadline
- 90 days (fee-for-service); 120 days after a plan appeal (managed care) source
- Primary source
- Florida Agency for Health Care Administration
- Date read
- August 2026
Florida is the opposite of a reversal story. There is no recent bulletin here, because nothing recently changed. The exclusion sits in a coverage policy the state adopted into its rules in 2017 and has not replaced, and it is written as a category rather than a drug list: weight control medications, alongside hair growth restorers and drugs for cosmetic use.
That 2017 date looks stale and is not. Florida proposed an amendment and withdrew it on March 14, 2024, so the adopted rule still carries its December 24, 2017 effective date and still points at the December 2017 handbook. The old date is the current rule.
In Florida the state's answer may not be your plan's answer. Most enrollees are in Statewide Medicaid Managed Care, and the statute has each plan publish "any" formulary or preferred drug list of its own rather than adopting the state's. Nothing in the three statutes most likely to say otherwise requires them to use the state list. So read what follows as the fee-for-service position and check your own plan's list before you rely on it.
What we could verify for Florida
Florida's coverage policy for prescribed drugs lists what the program does not pay for, and "Weight control medications" is one of the named entries — in the same list as drugs for cosmetic use, hair growth restorers, and drugs to treat infertility. This is a category exclusion, not a decision about any particular product.
Florida Agency for Health Care Administration, effective December 2017 · source
That policy is not merely guidance; it is written into Florida's rules. Rule 59G-4.250 incorporates by reference "Florida Medicaid Prescribed Drug Services Coverage Policy, December 2017," and the state's rule registry shows the latest adopted version with an effective date of 12/24/2017. A later amendment to the rule was proposed and then withdrawn on 3/14/2024, so the December 2017 document is the one in force.
Florida Administrative Code, Rule 59G-4.250, Florida Department of State, effective December 2017 · source
None of the weight-loss drugs is on Florida's drug list. Across the whole July 1, 2026 edition, Wegovy, Zepbound, Saxenda, Victoza and liraglutide appear nowhere. Ozempic and Mounjaro do, under the headings "ANTIHYPERGLY,INCRETIN MIMETIC(GLP-1 RECEP.AGONIST)" and "ANTIHYPERGLYCEMIC - INCRETIN MIMETICS COMBINATION," each marked Clinical PA with a minimum age of 18. What a list does not mention is not the same as a coverage decision, so read this as what the list says and no more.
Florida Agency for Health Care Administration, effective July 2026 · source
Florida gives managed care plans room to publish their own drug list: "Each managed care plan must publish any prescribed drug formulary or preferred drug list on the plan's website in a manner that is accessible to and searchable by enrollees and providers. The plan must update the list within 24 hours after making a change." We looked for a Florida statute or rule requiring plans to adopt the state's own list and did not find one in sections 409.912, 409.967 or 409.973.
Fla. Stat. §409.967(2)(c)2., Florida Legislature, effective 2026 Florida Statutes · source
Florida's appeal rule sets two different clocks, and which one you are on depends on your plan. In fee-for-service, "The Agency must receive the fair hearing request within 90 days of the date a required NOA is sent to the recipient." If you are in a managed care plan you must finish the plan's own appeal first — "An enrollee must initiate and complete a plan appeal before making a fair hearing request" — and then the state must receive your hearing request "within 120 days of the date the required NPAR is sent."
Florida Administrative Code, Rule 59G-1.100, Agency for Health Care Administration, effective September 2018 · source
Florida is one of 6 states whose Medicaid gives the same answer: weight loss excluded, and no other route named. Florida Medicaid's rule doesn't reach a job-based plan or Medicare. If you have one of those, read employer plans or Medicare Part D instead, and compare Florida with the rest in the coverage matrix.
Regional insurers that sell plans in Florida and have their own page here, quoted from their own policy documents: Florida Blue. The national insurers are on the insurance index.
If you work for the State of Florida
State employees aren't on Medicaid, so the answer above isn't yours. Your plan is the one the state buys for its workers: State Group Insurance Program. Its pharmacy benefit runs through Optum Rx.
Capped pilot program only
Florida covers weight-loss drugs, including Wegovy and Zepbound, only for members accepted into its Weight Management Program, a yearly pilot the Legislature has to approve, with a cap on how many people can join.
"Participants of the WMP are eligible for coverage of FDA-approved weight management medications as prescribed by their provider." The covered list includes "liraglutide (Saxenda)", "semaglutide (Wegovy) (Injectable and oral)" and "tirzepatide (Zepbound)".
Florida Division of State Group Insurance, Weight Management Program · source
"For 2027, the WMP will be open to 2,000 participants ... BMI ≥ 30 OR a BMI 27-29 and at least one weight-related comorbid condition (e.g., hypertension, high cholesterol). Age 18 and over."
Florida Division of State Group Insurance, Weight Management Program · source
The 2026 guide: "This program is available to 2,800 members who meet the eligibility criteria. It runs from Jan. 1 through Dec. 31 each year, pending approval by the Legislature."
Florida Division of State Group Insurance, Benefits Guide 2026, effective January 2026 · source
"The Pharmacy Benefits Manager for the State Employees' Prescription Drug Plan is Optum Rx."
Florida Division of State Group Insurance, Benefits Guide 2026, effective January 2026 · source
If the appeal fails, or you cannot wait
Florida Medicaid doesn't pay for these drugs for weight loss and names no other route, so if you're covered only by Medicaid here, paying cash may be the only way to get one. That means the whole cost, every month, with nothing counted toward your coverage.
These companies pay us a commission if you start care through the links below. That is how this site is funded, and it does not change what is written above. How we pay for this.
| Company | What we found on its own site |
|---|---|
| PartnerBodybuilding Health+Check availability | Compounded tirzepatide at $174.67 to $209 a month, lower the more months you buy at once; semaglutide is tiered the same way. Operated by Dynamo Group LLC. |
| PartnerStrut HealthCheck availability | A telehealth storefront where weight loss is one of six categories. No GLP-1 price is published on the page our link opens. |
| PartnerRxSpan MDCheck availability | Multi-category telehealth that promises transparent pricing, then publishes no GLP-1 price on the page our link opens. |
| PartnerSnagRxCheck availability | Compounded semaglutide at $69 a month and tirzepatide at $119, the same at every dose, with no membership. Both are countdown sale prices, marked down from $299 and $399. Not available in Louisiana. |
| PartnerSkinnyRxCheck availability | Compounded semaglutide and tirzepatide injections at $99 for the first month, tablets at $149 and $199. No second-month price is printed for any of them. |
| PartneryourEraCheck availability | Compounded semaglutide at $79.20 a month and tirzepatide at $159.20. Both are six-month-plan prices, and the plan carries a six-month commitment. |
All 21 companies, with what we found on each →
Prices in those notes were read from each company's own site in September 2026, and they change often. Check the current number before you buy.
Where this comes from
- Florida Agency for Health Care Administration, effective December 2017 — Open the document
- Florida Administrative Code, Rule 59G-4.250, Florida Department of State, effective December 2017 — Open the document
- Florida Agency for Health Care Administration, effective July 2026 — Open the document
- Fla. Stat. §409.967(2)(c)2., Florida Legislature, effective 2026 Florida Statutes — www.flsenate.gov/laws/statutes/2026/409.967
- Florida Administrative Code, Rule 59G-1.100, Agency for Health Care Administration, effective September 2018 — Open the document